Health Information Technology

1. Health Information Technology IHI Board HIT Working Group Oct 2008

2. Board HIT Working Group4th November • 10.30 – 1.00 pm for lunch • Bob Waller, Blan Godfrey, Mitch Seltzer, Paul Hamnett, Brian Robson, Don Goldmann, Don Berwick and Maureen Bisognano, Michael Iantosca, Abhijit Deshmukh • Paul / Brian - Facilitate • Minutes / note taker – Judy Kalman

3. Agenda • Introductions 1 minute overview of what you want to achieve today and what your interests are. • Aims & Objectives • High Level Presentation on HIT • Brian Robson • Our thoughts to date • Paul & Brian • Brain storming session

4. Aim & Objectives • Aim: • Establish a deep understanding of health information technology (HIT) and its role in high quality care; today, tomorrow and 5-10 years out. • Objectives:  • to provide knowledge, understanding and advice to IHI’s Board. • To provide a framework for IHI to develop a strategic and business plan at the interface of HIT and improvement • To identify potential ‘Demonstration Partners’ in HIT

5. High Level Presentation on HIT Brian Robson High Level Presentation on Worldwide HIT Please jump in with comments / questions

6. Aim & Objectives • Aim: • Establish a deep understanding of health information technology (HIT) and its role in high quality care; today, tomorrow and 5-10 years out. • Objectives:  • to provide knowledge, understanding and advice to IHI’s Board. • To provide a framework for IHI to develop a strategic and business plan at the interface of HIT and improvement • To identify potential ‘Demonstration Partners’ in HIT

7. Why do this ? • HIT plays a central, critical role in most health care systems – from policy to delivery. • Worldwide issue • Adoption of HIT viewed as indicator of quality of healthcare systems – e.g. US Scorecard • Positive evaluations of HIT (overall) • A number of potential ‘tipping point’ indicators: • ‘disruptive’ technologies ( e.g. web 2.0) in use • patient / consumer driven-e.g. Google Health, Healthvault. • others • IHI has been approached by major players

8. Why IHI? • Is IHI behind the curve on HIT ? • Does IHI have a clear organizational view on value of HIT? • Do customers perceive IHI to support HIT ? • Do our staff and faculty have deep understanding ? • Can our view be modernized ? • Opportunity to lead as improvement organization • IHI has unique perspective and ‘bridging’ role • We know our customers’ problem areas • We have nurtured an improvement network • We have many connections with HIT experts  IHI could bridge the two

9. Why IHI ? ( continued !) • IHI have library of previous activity e.g. ARHQ report, Don Berwick’s report on Partners, input into KP HealthConnect development, etc • Board enthusiasm, expertise and energy • Willing and able leaders – Don G, Paul H and Brian R

10. Where are we now? • Initial Board working group discussions • Team formed Bob Waller, Blan Godfrey, Mitch Seltzer,Don Goldman, Paul Hamnett, Brian Robson • HIT contact list drafted

11. How take forward ? • Initial Board contributions • Establish ‘unofficial’ R&D project (off cycle) • Alignment within core IHI work • Structure • Timelines • Visibility and awareness • Resource, critique and support • Collaborate with R&D (Merck) project • Contribute as Core Member of the NHS ‘Connecting for Health’ Benefits Realization Network – six month project

12. Pace of Work Scan - Dec • Deliverables: • Write and post technical brief • Subject matter expert interviews • Post all research documents team should read • Progress report Peer Review & Test - Jan • Deliverables: • Updated technical brief • Initial formulation of outcomes • Testing and outcomes of testing • Progress report Summarize and Disseminate (Focus) - Feb • Deliverables: (Final deliverables – see brainstorming session) • 90-Day Report • Report to IHI Innovation Team - ? Future whitepaper • Report to IHI Board

13. Return on investment ( non $) Primary • Knowledge and understanding for IHI • Inform IHI strategy on HIT Secondary • Raise profile of IHI in HIT field • White paper  ‘get our thoughts out there’

14. Return on investment ( $) • Future Forum sessions • Special event(s) – seminars, collaborations • Consider RFP $ and other grants • Other

15. Next Steps • Inform Board of R&D recommendation (BR, MB) –done • Link with Merck R&D team (BR, JH, JW) - done • R&D submission • Intention flagged to LM and DG • SBAR to be submitted before 1st Nov ( BR) • Launch Nov 1st • Charter to be written by 11th Nov (BR, PH)

16. In summary • HIT is important to our customers and to IHI • IHI has opportunity to evolve its position on HIT • Board level support • R&D route is recommended

17. Board HIT Working Group • Now • further draft HIT contact list • draft questionnaire • share R&D recommendation with working group

18. Board HIT Working Group • What areas of Healthcare IT should we be investigating? Multi-vote Priorities • Who within these areas should we talk to

19. Board HIT Working Group • How should we complete the research? • What should the deliverables be?

20. Board HIT Working Group • What questions should we ask? • Can you describe your role in your organization to me ? • Where does quality improvement, risk management or patient safety fit in that role ? • Do you have a role in health information technologies in your system ? • Where do you see HIT’s contribution to quality improvement ? • Do you view HIT as an enabler in improvement efforts? • Where do you see failures of HIT ? • Can you point us to or describe examples of above ? • How might you wish to see IHI’s role evolve in this field ?